CompletedNCT06282146
Personalized magnetic stimulation target for depression
About this title
Read the official source — NCT06282146Interventional studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- BostonSee all locations and recruitment
Study information
Study start dateStarted: September 9, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Brigham and Women's Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Procedure
- Intervention type
- Procedure
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06282146
- Official title
Show the full official title
Testing a Transdiagnostic TMS Treatment Target
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Brigham and Women's Hospital, a hospital or academic medical center.
Who was this study for?
Listed age limits: 18 years to 65 years.
